The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer - PubMed (original) (raw)

The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer

P A McArdle et al. Br J Cancer. 2004.

Abstract

The relationship between tumour stage, T-lymphocyte subset infiltration and survival was examined in patients with prostate cancer (n=80). On multivariate analysis PSA (HR 2.47, 95% CI 1.27-4.83, P=0.008) and CD4+ T-lymphocyte count (HR 2.29, 95% CI 1.25-4.22, P=0.008) had independent significance. Increased CD4+ T-lymphocyte infiltration within the tumour was stage independent and associated with poor outcome in patients with prostate cancer.

PubMed Disclaimer

Similar articles

• Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
  Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO. Cheng L, et al. J Urol. 2005 Dec;174(6):2181-5. doi: 10.1097/01.ju.0000181215.41607.c3. J Urol. 2005. PMID: 16280760
• Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
  Ebelt K, Babaryka G, Figel AM, Pohla H, Buchner A, Stief CG, Eisenmenger W, Kirchner T, Schendel DJ, Noessner E. Ebelt K, et al. Prostate. 2008 Jan 1;68(1):1-10. doi: 10.1002/pros.20661. Prostate. 2008. PMID: 17948280
• Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
  Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L. Ploussard G, et al. BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30. BJU Int. 2011. PMID: 20883488
• Tumour-infiltrating lymphocytes: A prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy.
  Kärjä V, Aaltomaa S, Lipponen P, Isotalo T, Talja M, Mokka R. Kärjä V, et al. Anticancer Res. 2005 Nov-Dec;25(6C):4435-8. Anticancer Res. 2005. PMID: 16334122
• Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.
  Vergis R, Corbishley CM, Norman AR, Bartlett J, Jhavar S, Borre M, Heeboll S, Horwich A, Huddart R, Khoo V, Eeles R, Cooper C, Sydes M, Dearnaley D, Parker C. Vergis R, et al. Lancet Oncol. 2008 Apr;9(4):342-51. doi: 10.1016/S1470-2045(08)70076-7. Epub 2008 Mar 17. Lancet Oncol. 2008. PMID: 18343725

Cited by

• Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk.
  Rasmussen M, Fredsøe J, Salachan PV, Blanke MPL, Larsen SH, Ulhøi BP, Jensen JB, Borre M, Sørensen KD. Rasmussen M, et al. NPJ Precis Oncol. 2024 Feb 23;8(1):48. doi: 10.1038/s41698-024-00540-x. NPJ Precis Oncol. 2024. PMID: 38395986 Free PMC article.
• The Relationship Between Lymphocyte Subtypes with Clinicopathological Features and Prognosis of Prostate Cancer in Patients Undergoing Radical Prostatectomy.
  Sendogan F, Turan T, Erman H, Danacioglu YO, Isman FK, Atis RG, Silay MS, Caskurlu T, Yildirim A. Sendogan F, et al. Urol Res Pract. 2023 Jul;49(4):253-258. doi: 10.5152/tud.2023.22220. Urol Res Pract. 2023. PMID: 37877827 Free PMC article.
• Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma.
  Li Y, Xiong C, Wu LL, Zhang BY, Wu S, Chen YF, Xu QH, Liao HF. Li Y, et al. Pathol Oncol Res. 2023 Jun 9;29:1610980. doi: 10.3389/pore.2023.1610980. eCollection 2023. Pathol Oncol Res. 2023. PMID: 37362244 Free PMC article.
• The predictive value of CD4, CD8, and C-reactive protein in the prognosis of schistosomal and non-schistosomal colorectal cancer.
  Cheng M, Jing H, Bu D, Liu J, Lu K, Liu J, Xu Y, Zhu T, Hou Y, Yao J, Zhai Q, Wang W. Cheng M, et al. BMC Gastroenterol. 2023 Jun 5;23(1):194. doi: 10.1186/s12876-023-02834-z. BMC Gastroenterol. 2023. PMID: 37277702 Free PMC article.
• Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study.
  Diop MK, Molina OE, Birlea M, LaRue H, Hovington H, Têtu B, Lacombe L, Bergeron A, Fradet Y, Trudel D. Diop MK, et al. Cancers (Basel). 2023 Apr 9;15(8):2217. doi: 10.3390/cancers15082217. Cancers (Basel). 2023. PMID: 37190147 Free PMC article.

References

1. 1. Ali AA, McMillan DC, Matalka II, McNicol AM, McArdle CS (2004) Tumour T-lymphocyte subset infiltration and tumour recurrence following curative resection for colorectal cancer. Eur J Surg Oncol 30: 292–295 - PubMed
2. 1. Anderson JA, Dunnill MS (1965) Observations on the estimation of the quantity of emphysema in the lungs by the point-sampling method. Thorax 20: 462–466
3. 1. Bromwich EJ, McArdle PA, Canna K, McMillan DC, McNicol A-M, Brown M, Aitchison M (2003) The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Br J Cancer 89: 1906–1908 - PMC - PubMed
4. 1. Chodak GW, Thisted RA, Gerber GS, Johansson J-E, Adolfsson J, Jones GW, Chisolm GD, Moskovitz B, Livne PM, Warner J (1994) Results of conservative management of clinically localized prostate cancer. N Eng J Med 330: 242–248 - PubMed
5. 1. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917): 860–867 - PMC - PubMed

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal